News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
455,930 Results
Type
Article (23511)
Company Profile (180)
Press Release (432223)
Multimedia
Podcasts (116)
Webinars (19)
Section
Business (135567)
Career Advice (1066)
Deals (24708)
Drug Delivery (115)
Drug Development (53996)
Employer Resources (89)
FDA (11120)
Job Trends (10321)
News (230282)
Policy (20550)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1151)
Accelerated approval (19)
Adcomms (23)
Allergies (104)
Alliances (37742)
ALS (98)
Alzheimer's disease (930)
Antibody-drug conjugate (ADC) (220)
Approvals (11356)
Artificial intelligence (456)
Autoimmune disease (88)
Automation (34)
Bankruptcy (211)
Best Places to Work (7888)
BIOSECURE Act (15)
Biosimilars (178)
Biotechnology (85)
Bladder cancer (84)
Brain cancer (39)
Breast cancer (340)
Cancer (2832)
Cardiovascular disease (283)
Career advice (895)
Career pathing (27)
CAR-T (132)
CDC (15)
Cell therapy (380)
Cervical cancer (17)
Clinical research (47234)
Collaboration (1362)
Company closure (1)
Compensation (429)
Complete response letters (53)
COVID-19 (1435)
CRISPR (74)
C-suite (648)
Cystic fibrosis (96)
Data (3868)
Decentralized trials (2)
Denatured (31)
Depression (96)
Diabetes (318)
Diagnostics (4212)
Digital health (35)
Diversity (10)
Diversity, equity & inclusion (27)
Drug discovery (199)
Drug pricing (204)
Drug shortages (33)
Duchenne muscular dystrophy (142)
Earnings (51944)
Editorial (46)
Employer branding (10)
Employer resources (86)
Events (66601)
Executive appointments (775)
FDA (13309)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (956)
Gene editing (125)
Generative AI (41)
Gene therapy (335)
GLP-1 (864)
Government (2433)
Grass and pollen (5)
Guidances (289)
Healthcare (10112)
HIV (43)
Huntington's disease (25)
IgA nephropathy (62)
Immunology and inflammation (170)
Immuno-oncology (38)
Indications (83)
Infectious disease (1607)
Inflammatory bowel disease (132)
Inflation Reduction Act (12)
Influenza (67)
Intellectual property (173)
Interviews (145)
IPO (10141)
IRA (54)
Job creations (2672)
Job search strategy (770)
JPM (52)
Kidney cancer (10)
Labor market (63)
Layoffs (359)
Leadership (32)
Legal (4778)
Liver cancer (42)
Longevity (11)
Lung cancer (391)
Lymphoma (232)
Machine learning (32)
Management (33)
Manufacturing (665)
MASH (107)
Medical device (8131)
Medtech (8167)
Mergers & acquisitions (15368)
Metabolic disorders (974)
Multiple sclerosis (108)
NASH (20)
Neurodegenerative disease (190)
Neuropsychiatric disorders (72)
Neuroscience (1742)
Neurotech (1)
NextGen: Class of 2026 (4019)
Non-profit (1709)
Now hiring (47)
Obesity (537)
Opinion (251)
Ovarian cancer (75)
Pain (184)
Pancreatic cancer (125)
Parkinson's disease (177)
Partnered (24)
Patents (362)
Patient recruitment (308)
Peanut (31)
People (42183)
Pharmaceutical (80)
Pharmacy benefit managers (33)
Phase 1 (14754)
Phase 2 (19884)
Phase 3 (16108)
Pipeline (3590)
Policy (243)
Postmarket research (1719)
Preclinical (5329)
Press Release (43)
Prostate cancer (166)
Psychedelics (29)
Radiopharmaceuticals (212)
Rare diseases (587)
Real estate (4043)
Recruiting (35)
Regulatory (16367)
Reports (29)
Research institute (1224)
Resumes & cover letters (168)
Rett syndrome (10)
RNA editing (14)
RSV (48)
Schizophrenia (123)
Series A (166)
Series B (119)
Service/supplier (13)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (122)
Sponsored (32)
Startups (2471)
State (2)
Stomach cancer (12)
Supply chain (98)
Tariffs (94)
The Weekly (83)
Vaccines (500)
Venture capital (75)
Weight loss (383)
Women's health (63)
Worklife (13)
Date
Today (2)
Last 7 days (401)
Last 30 days (1496)
Last 365 days (19791)
2026 (1947)
2025 (20106)
2024 (23427)
2023 (26141)
2022 (34474)
2021 (37155)
2020 (36139)
2019 (30387)
2018 (23053)
2017 (22450)
2016 (21221)
2015 (24265)
2014 (18900)
2013 (16085)
2012 (17245)
2011 (17451)
2010 (15663)
Location
Africa (501)
Alabama (55)
Alaska (2)
Arizona (157)
Arkansas (9)
Asia (30935)
Australia (4028)
California (6455)
Canada (2229)
China (839)
Colorado (333)
Connecticut (275)
Delaware (261)
Europe (66228)
Florida (1133)
Georgia (238)
Hawaii (3)
Idaho (54)
Illinois (653)
India (62)
Indiana (440)
Iowa (13)
Japan (355)
Kansas (101)
Kentucky (35)
Louisiana (13)
Maine (29)
Maryland (785)
Massachusetts (4778)
Michigan (205)
Minnesota (509)
Mississippi (6)
Missouri (95)
Montana (28)
Nebraska (21)
Nevada (65)
New Hampshire (53)
New Jersey (2212)
New Mexico (26)
New York (1663)
North Carolina (1072)
North Dakota (9)
Northern California (3013)
Ohio (223)
Oklahoma (13)
Oregon (33)
Pennsylvania (1361)
Puerto Rico (19)
Rhode Island (36)
South America (779)
South Carolina (58)
South Dakota (1)
Southern California (2611)
Tennessee (107)
Texas (1010)
United States (24732)
Utah (163)
Vermont (1)
Virginia (221)
Washington D.C. (69)
Washington State (498)
West Virginia (3)
Wisconsin (106)
Wyoming (2)
455,930 Results for "piramal pharma solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
February 3, 2026
·
5 min read
Press Releases
Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
November 27, 2025
·
5 min read
Press Releases
Piramal Pharma Limited Announces Results for Q3 and 9M FY26
January 29, 2026
·
7 min read
Press Releases
Piramal Pharma Solutions’ Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
November 19, 2025
·
3 min read
Press Releases
Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities
October 30, 2025
·
4 min read
Press Releases
Piramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal’s Sellersville, Pennsylvania Site
August 21, 2025
·
6 min read
Press Releases
Piramal Pharma Limited Announces Results for Q2 and H1 FY26
November 6, 2025
·
7 min read
Press Releases
Piramal Pharma Solutions Supports George Medicines in Developing its New Drug for Hypertension, WIDAPLIK™ (telmisartan, amlodipine and indapamide)
August 29, 2025
·
9 min read
Press Releases
Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility
September 17, 2025
·
4 min read
Press Releases
Piramal Pharma Limited Announces Results for Q1FY26
July 29, 2025
·
6 min read
1 of 45,593
Next
